Status:
UNKNOWN
Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Uremia
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim of this study is to examine removal of protein bound uremic substances by mFPSA in chronic hemodialysis patients. mFPSA is an extracorporal blood purification system developed for detoxificati...
Detailed Description
Measurements of uremic protein bound substances before and after mFPSA and a preceding routine hemodialysis session.
Eligibility Criteria
Inclusion
- Over the age of 18
- Anuria
- Chronic hemodialysis dependence
Exclusion
- No present history of bleeding episodes
- Cardiac diseases
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00375635
Start Date
March 1 2006
End Date
October 1 2006
Last Update
September 13 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Copenhagen, Denmark, 2200